These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 22536884

  • 21. Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial.
    Mok CC, Wong CK, To CH, Lai JP, Lam CS.
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):875-83. PubMed ID: 21309005
    [Abstract] [Full Text] [Related]

  • 22. Attenuation of rate of change in carotid intima-media thickness by lipid-modifying drugs: impact on clinical outcomes.
    Peters SA, den Ruijter HM, Bots ML.
    Am J Cardiovasc Drugs; 2011 Aug 01; 11(4):253-63. PubMed ID: 21657803
    [Abstract] [Full Text] [Related]

  • 23. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
    Davidson M, Meyer PM, Haffner S, Feinstein S, D'Agostino R, Kondos GT, Perez A, Chen Z, Mazzone T.
    Circulation; 2008 Apr 22; 117(16):2123-30. PubMed ID: 18413496
    [Abstract] [Full Text] [Related]

  • 24. The impact of variability in ultrasound settings on the measured echolucency of the carotid intima-media.
    Peters SA, Bots ML, Lind L, Groenewegen KA, de Korte C, den Ruijter HM, METEOR study group.
    J Hypertens; 2013 Sep 22; 31(9):1861-7. PubMed ID: 23868083
    [Abstract] [Full Text] [Related]

  • 25. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations?
    Bots ML, Baldassarre D, Simon A, de Groot E, O'Leary DH, Riley W, Kastelein JJ, Grobbee DE.
    Eur Heart J; 2007 Feb 22; 28(4):398-406. PubMed ID: 17277033
    [Abstract] [Full Text] [Related]

  • 26. Paradoxical progression of atherosclerosis related to low-density lipoprotein reduction and exposure to ezetimibe.
    Taylor AJ, Villines TC, Stanek EJ.
    Eur Heart J; 2012 Dec 22; 33(23):2939-45. PubMed ID: 22564353
    [Abstract] [Full Text] [Related]

  • 27. Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
    Longenecker CT, Sattar A, Gilkeson R, McComsey GA.
    AIDS; 2016 Sep 10; 30(14):2195-203. PubMed ID: 27203715
    [Abstract] [Full Text] [Related]

  • 28. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML, Evans GW, Riley W, McBride KH, Paskett ED, Helmond FA, Grobbee DE, OPAL Investigators.
    Eur Heart J; 2006 Mar 10; 27(6):746-55. PubMed ID: 16415304
    [Abstract] [Full Text] [Related]

  • 29. A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes.
    Stocker DJ, Taylor AJ, Langley RW, Jezior MR, Vigersky RA.
    Am Heart J; 2007 Mar 10; 153(3):445.e1-6. PubMed ID: 17307426
    [Abstract] [Full Text] [Related]

  • 30. Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
    Davidson MH, Rosenson RS, Maki KC, Nicholls SJ, Ballantyne CM, Mazzone T, Carlson DM, Williams LA, Kelly MT, Camp HS, Lele A, Stolzenbach JC.
    Arterioscler Thromb Vasc Biol; 2014 Jun 10; 34(6):1298-306. PubMed ID: 24743431
    [Abstract] [Full Text] [Related]

  • 31. Carotid intima-media thickness measurement in cardiovascular screening programmes.
    Plantinga Y, Dogan S, Grobbee DE, Bots ML.
    Eur J Cardiovasc Prev Rehabil; 2009 Dec 10; 16(6):639-44. PubMed ID: 19752735
    [Abstract] [Full Text] [Related]

  • 32. Lessons from the past and promises for the future for carotid intima-media thickness.
    Bots ML, Sutton-Tyrrell K.
    J Am Coll Cardiol; 2012 Oct 23; 60(17):1599-604. PubMed ID: 22999720
    [Abstract] [Full Text] [Related]

  • 33. Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia.
    Igase M, Kohara K, Tabara Y, Nagai T, Ochi N, Kido T, Ochi M, Miki T.
    Menopause; 2012 Dec 23; 19(12):1294-9. PubMed ID: 22850442
    [Abstract] [Full Text] [Related]

  • 34. Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.
    Cakal E, Turgut AT, Demirbas B, Ozkaya M, Cakal B, Serter R, Aral Y.
    Exp Clin Endocrinol Diabetes; 2009 Jun 23; 117(6):294-300. PubMed ID: 19085705
    [Abstract] [Full Text] [Related]

  • 35. Change in body mass index from adolescence to young adulthood and increased carotid intima-media thickness at 28 years of age: the Atherosclerosis Risk in Young Adults study.
    Oren A, Vos LE, Uiterwaal CS, Gorissen WH, Grobbee DE, Bots ML.
    Int J Obes Relat Metab Disord; 2003 Nov 23; 27(11):1383-90. PubMed ID: 14574350
    [Abstract] [Full Text] [Related]

  • 36. Results from a carotid intima-media thickness trial as a decision tool for launching a large-scale morbidity and mortality trial.
    Peters SA, den Ruijter HM, Grobbee DE, Bots ML.
    Circ Cardiovasc Imaging; 2013 Jan 01; 6(1):20-5. PubMed ID: 23204038
    [Abstract] [Full Text] [Related]

  • 37. Ultrasound protocols to measure carotid intima-media thickness: a post-hoc analysis of the OPAL study.
    Dogan S, Plantinga Y, Evans GW, Meijer R, Grobbee DE, Bots ML, OPAL investigators.
    Curr Med Res Opin; 2009 Jan 01; 25(1):109-22. PubMed ID: 19210144
    [Abstract] [Full Text] [Related]

  • 38. [Prevalence of subclinical atherosclerosis and cardiovascular risk reclassification by measure of carotid intima-media thickness in ambulatory hypertensive patients].
    Monteiro Júnior Fd, Pereira da Cunha Júnior C, Muniz Ferreira PA, Teixeira Nunes JA, Lopes Brito R, Barbosa JB, Ribeiro Mandarino N, Santos Lages J, Salgado Filho N, Correia de Lima V.
    Rev Port Cardiol; 2013 Dec 01; 32(12):975-80. PubMed ID: 24287019
    [Abstract] [Full Text] [Related]

  • 39. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view.
    Bots ML, Evans GW, Riley WA, Grobbee DE.
    Stroke; 2003 Dec 01; 34(12):2985-94. PubMed ID: 14615619
    [Abstract] [Full Text] [Related]

  • 40. Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes.
    Xiang AH, Peters RK, Kjos SL, Ochoa C, Marroquin A, Goico J, Tan S, Wang C, Azen SP, Liu CR, Liu CH, Hodis HN, Buchanan TA.
    J Clin Endocrinol Metab; 2005 Apr 01; 90(4):1986-91. PubMed ID: 15623809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.